Foraviset Ltd.

Foraviset is a women's health-focused biopharmaceutical company developing non-hormonal therapies for uterine disorders, including endometriosis.

Biotechnology
Active
Jerusalem, Israel Founded 2018
Website ↗
Last updated 2026-08-21
Total raised
Stage
Founded
2018
Headcount
HQ
Jerusalem, Israel
Sector
Biotechnology

About

Foraviset is a women's health-focused biopharmaceutical company dedicated to transforming women's health by developing non-hormonal therapies for uterine disorders, particularly endometriosis. The company is pioneering Raviset®, a first-in-class, non-hormonal, non-surgical therapy that targets the root cause of inflammation through the inducible Nitric Oxide Synthase (iNOS) pathway. With over two decades of research, compelling clinical outcomes, and a robust IP portfolio, Raviset® aims to deliver safe, effective, and fertility-compatible relief. Foraviset is currently preparing for a Phase IIa clinical trial for Raviset® in endometriosis.

Funding history · 1 round · — total

2026-08
A Round Undisclosed

Q&A

What is Foraviset Ltd.'s primary focus?
Foraviset Ltd. is a women's health-focused biopharmaceutical company developing non-hormonal therapies for uterine disorders, particularly endometriosis.
When was Foraviset Ltd. founded?
Foraviset Ltd. was founded in 2018.
What is the name of Foraviset Ltd.'s lead product candidate?
Foraviset Ltd. is pioneering Raviset®, a first-in-class, non-hormonal, non-surgical therapy.
What is the mechanism of action for Raviset®?
Raviset® targets the root cause of inflammation through the inducible Nitric Oxide Synthase (iNOS) pathway.
What is the current clinical trial stage for Raviset®?
Foraviset Ltd. is currently preparing for a Phase IIa clinical trial for Raviset® in endometriosis.
Who is the CEO and Co-Founder of Foraviset Ltd.?
Jacob Marx is the CEO & Co-Founder of Foraviset Ltd., appointed in August 2018.
What is Foraviset Ltd.'s primary sector?
Foraviset Ltd.'s primary sector is Biotechnology.
Has Foraviset Ltd. raised any funding rounds?
Yes, Foraviset Ltd. completed an A Round in August 2026.

Team · 5

Jacob Marx
Founder · CEO & Co-Founder
Dr. Yuval Kaufman
CSO
Prof. Uri Dior
CMO
Mr. Itay Cohen
CFO
Moran Faibish
Chief Marketing Officer

Sectors & technology

Primary sector
Biotechnology
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteforaviset.com

Identifiers & details

Legal nameFORAVISET LTD
Founded2018